(Q44909702)

7 December 2017

title

Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma (English)

1 reference

7 December 2017

0 references

2

1 reference

7 December 2017

8

1 reference

7 December 2017

Domingo Morales

1

1 reference

7 December 2017

Fernando Hurtado De Mendoza

3

1 reference

7 December 2017

Luis Riva

4

1 reference

7 December 2017

Alejandro Yabar

5

1 reference

7 December 2017

Pilar Quiñones

6

1 reference

7 December 2017

James N Butera

7

1 reference

7 December 2017

publication date

1 January 2010

1 reference

7 December 2017

1 reference

7 December 2017

volume

51

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

66-72

1 reference

An update of the epidemiology of non-Hodgkin's lymphoma

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

The risk of lymphoma development in autoimmune diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

EBV-associated lymphoproliferative disorders: classification and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Association between simian virus 40 and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Epstein-Barr virus and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

Unconscious bias and how clinicians can address racial inequities in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903308015

10.3109/10428190903308015

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference